This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Subacute cutaneous lupus erythematosus

Authoring team

This form of LE comprises up to 10% of SLE cases and is characterised by the presence of persistent macular or slightly raised erythematous lesions on the upper trunk and arms. Females are affected more than males.

Serology:

  • circulating anti-Ro, anti-La antibodies and rheumatoid factor may be found.
  • mild hypocomplimentaemia.

Features:

  • tends to be benign - life-threatening systemic involvement tends to be uncommon.

Treatment:

  • topical steroids and intralesional steroids.
  • if topical therapy is not sufficient then alternatives include:
    • prednisolone and cytotoxic drugs
    • other antimalarial drugs eg mepacrine. Mepacrine may be used in combination with hydroxychloroquine

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.